E-LIB Suche - Ergebnisse für: Fleury, Isabelle

1

Canadian cancer trials group LY.17: A randomized phase II s..:

Stewart, Douglas A. ; Kuruvilla, John ; Lee, David...
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

2

Author Correction: Lisocabtagene maraleucel in follicular l..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

3

Lisocabtagene maraleucel in follicular lymphoma: the phase ..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

4

Impact of Implementing a Bendamustine-Based Conditioning Re..:

Lachance, Sylvie ; Bourguignon, Alex ; Boisjoly, Josie-Anne...
Transplantation and Cellular Therapy. 29 (2023) 1 - p. 34.e1-34.e7 , 2023

Link: https://doi.org/10.1016/..

5

POSTER: IBCL-098 TRANSCEND FL: Phase II Study Results of Li..:

Nastoupil, Loretta J. ; Dahiya, Saurabh ; Palomba, M. Lia...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S209 , 2023

Link: https://doi.org/10.1016/..

6

Oral Abstract: IBCL-098 TRANSCEND FL: Phase II Study Result..:

Nastoupil, Loretta J. ; Dahiya, Saurabh ; Palomba, M. Lia...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S147 , 2023

Link: https://doi.org/10.1016/..

7

Impact of Fixed-Duration Oral Targeted Therapies on the Eco..:

Lachaine, Jean ; Guinan, Kimberly ; Aw, Andrew...
Current Oncology. 30 (2023) 5 - p. 4483-4498 , 2023

Link: https://doi.org/10.3390/..

8

P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CH..:

Lansigan, Frederick ; A. Eyre, Toby ; Ghosh, Nilanjan...
HemaSphere. 7 (2023) S3 - p. e6855326 , 2023

Link: https://doi.org/10.1097/..

9

Treatment Discontinuation Patterns for Patients With Chroni..:

Shadman, Mazyar ; Manzoor, Beenish S. ; Sail, Kavita...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 7 - p. 515-526 , 2023

Link: https://doi.org/10.1016/..

10

Safety and efficacy of tisagenlecleucel plus pembrolizumab ..:

Jaeger, Ulrich ; Worel, Nina ; McGuirk, Joseph P....
Blood Advances. 7 (2023) 11 - p. 2283-2286 , 2023

Link: https://doi.org/10.1182/..

11

P647: RACIAL DISPARITIES IN REAL-WORLD TREATMENT PATTERNS A..:

Rhodes, Joanna ; Shadman, Mazyar ; Lamanna, Nicole...
HemaSphere. 7 (2023) S3 - p. e96103aa , 2023

Link: https://doi.org/10.1097/..

12

IBCL-098 TRANSCEND FL: Phase II Study Results of Lisocabtag..:

Nastoupil, Loretta J. ; Dahiya, Saurabh ; Palomba, M. Lia...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S447-S448 , 2023

Link: https://doi.org/10.1016/..

13

RE-MIND2: comparative effectiveness of tafasitamab plus len..:

Nowakowski, Grzegorz S. ; Yoon, Dok Hyun ; Mondello, Patrizia...
Annals of Hematology. 102 (2023) 7 - p. 1773-1787 , 2023

Link: https://doi.org/10.1007/..

14

Correction to: RE‑MIND2: comparative effectiveness of tafas..:

Nowakowski, Grzegorz S. ; Yoon, Dok Hyun ; Mondello, Patrizia...
Annals of Hematology. 102 (2023) 9 - p. 2643-2644 , 2023

Link: https://doi.org/10.1007/..

15

Real-World Outcomes of Autologous and Allogeneic Hematopoie..:

Veilleux, Olivier ; Claveau, Jean-Sébastien ; Alaoui, Habiba...
Transplantation and Cellular Therapy. 28 (2022) 3 - p. 145-151 , 2022

Link: https://doi.org/10.1016/..